Chuck Akre - Akre Capital Management Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Chuck Akre, the legendary value investor behind Akre Capital Management, showcases his unwavering focus on exceptional compounders in the latest 13F filing. His $9.1B Q4 2025 portfolio highlights a disciplined approach to portfolio management, with significant trims in high-conviction names alongside bold additions that signal confidence in select growth opportunities amid market volatility.
Portfolio Overview: The Art of Extreme Concentration
Portfolio Highlights (Q4 2025): - Market Value: $9,120.7M - Top 10 Holdings: 93.2% - Portfolio Size: 18 -1 - Average Holding Period: 35 quarters - Turnover: 5.6%
Akre Capital's portfolio remains a textbook example of ultra-concentrated investing, where over 93% of the $9.1 billion AUM resides in just the top 10 positions. This structure underscores Akre's philosophy of owning a handful of "compounding machines"—businesses capable of generating superior returns over decades through reinvested earnings and economic moats. The slight reduction in portfolio size to 18 positions -1 reflects ongoing refinement rather than panic selling, with low turnover at 5.6% indicating patience in holding winners.
The average holding period of 35 quarters (nearly 9 years) speaks volumes about conviction. Akre isn't chasing short-term trends; he's building a portfolio for multi-decade compounding. Recent moves show active management within this framework: trimming overweight positions to lock in gains while adding to names with expanding moats. This balance of discipline and opportunism in the Q4 2025 portfolio positions it well for uncertain markets, prioritizing quality over diversification.
Viewed through ValueSense's intrinsic value lens, these holdings emphasize businesses trading at premiums justified by durable competitive advantages. The concentration amplifies returns when right but demands rigorous ongoing analysis—precisely what Akre Capital delivers.
Top Holdings: Trims in Giants, Bets on Hidden Compounders
The portfolio's core remains anchored by payment giants and asset managers, with notable adjustments across the board. Leading the pack is Mastercard (MA) at 18.8%, though trimmed by 4.76%—likely profit-taking after strong performance. Brookfield Corporation (BN) surged to 13.5% with a massive 39.69% addition, signaling Akre's enthusiasm for its real asset empire and capital allocation prowess. KKR & Co. (KKR) holds at 11.3% but saw a 6.97% reduction, while Visa (V) dropped 9.99% to 10.3%, reflecting rebalancing in the payments duopoly.
Further down, Moody's (MCO) was cut 18.11% to 9.7%, and O'Reilly Automotive (ORLY) shed a hefty 21.98% to 6.7%, possibly to fund new opportunities. Additions shine through with CoStar Group (CSGP) up 3.35% to 7.1% and Fair Isaac (FICO) boosted 6.36% to 5.1%. Roper Technologies (ROP) was lightly reduced 4.45% to 5.4%, while Airbnb (ABNB) stayed steady at 5.2% with no change.
Beyond the top ranks, Copart (CPRT) received an aggressive 85.71% add to 3.4%, highlighting Akre's hunt for under-the-radar scalers in niche markets. These moves blend caution in mature leaders with aggression in moat-expanders, maintaining the portfolio's focus on high-quality growth.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
What the Portfolio Reveals About Akre's Strategy
Akre's Q4 adjustments reveal a strategy laser-focused on quality compounders over speculative growth. Trims in stalwarts like MA, V, and ORLY suggest profit-taking to manage concentration risk, while adds in BN and CPRT point to opportunities in asset-light, capital-efficient models.
Key themes emerge: - Sector tilt toward financials and tech-enabled services: Payments (MA, V), credit ratings (MCO), private equity (KKR, BN), and software (CSGP, ROP, FICO) dominate, favoring oligopolies with pricing power. - Moat preservation amid valuations: Reductions in pricier names like ORLY (down 22%) balance the portfolio without abandoning conviction. - Risk management via low turnover: At 5.6%, changes are surgical, preserving the 35-quarter average hold. - Global exposure with U.S. core: BN adds international flavor, but the portfolio stays U.S.-heavy for regulatory stability.
This isn't momentum chasing—it's moat investing, betting on businesses that widen advantages over time.
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Mastercard Incorporated (MA) | $1,715.7M | 18.8% | Reduce 4.76% |
| Brookfield Corporation (BN) | $1,231.9M | 13.5% | Add 39.69% |
| KKR & Co. Inc. (KKR) | $1,033.4M | 11.3% | Reduce 6.97% |
| Visa Inc. (V) | $938.7M | 10.3% | Reduce 9.99% |
| Moody's Corporation (MCO) | $886.4M | 9.7% | Reduce 18.11% |
| CoStar Group, Inc. (CSGP) | $646.7M | 7.1% | Add 3.35% |
| O'Reilly Automotive, Inc. (ORLY) | $612.9M | 6.7% | Reduce 21.98% |
| Roper Technologies, Inc. (ROP) | $491.9M | 5.4% | Reduce 4.45% |
| Airbnb, Inc. (ABNB) | $471.4M | 5.2% | No change |
| Fair Isaac Corporation (FICO) | $469.1M | 5.1% | Add 6.36% |
This table crystallizes Akre Capital's high-conviction model: the top 10 command 93.2% of the portfolio, with MA and BN alone at over 32%. The trims—totaling significant reductions in ORLY, MCO, and payments stocks—freed up capital for BN's outsized add, demonstrating dynamic position sizing. No single name exceeds 19%, mitigating blow-up risk while allowing winners like the steady ABNB to breathe.
Such concentration demands deep conviction, but Akre's track record validates it: low turnover ensures tax efficiency and compounding, while changes like CPRT's addition (outside top 10) show flexibility without diluting focus.
Investment Lessons from Chuck Akre's Compounder Strategy
Chuck Akre's approach offers timeless principles for building enduring wealth: - Own exceptional compounders: Prioritize businesses with wide moats and reinvestment runways, like MA and ROP, even at premiums—quality trumps cheapness. - Extreme concentration with discipline: 93% in top 10 works only with rigorous analysis; diversify mediocrity, concentrate brilliance. - Trim winners surgically: Reductions in ORLY 22% and MCO 18% lock gains without selling conviction names entirely. - Long holding periods pay off: 35 quarters average reflects patience; turnover at 5.6% minimizes friction. - Capital allocation is king: Adds to BN 40% and CPRT 86% reward superior allocators in uncertain times.
These lessons, drawn from Akre's portfolio evolution, emphasize understanding businesses deeply before sizing bets.
Looking Ahead: What Comes Next?
With turnover low and portfolio size trimmed to 18, Akre Capital appears poised for opportunistic deployment. Proceeds from trims in ORLY and MCO could fuel further adds in undervalued compounders, especially if markets correct—ValueSense screens highlight similar moat stocks trading below intrinsic value.
Financials and tech services remain sweet spots, with BN's ramp suggesting interest in alternative assets amid rate uncertainty. Current positioning sets up for resilience: payments oligopolies weather recessions, while ABNB and CSGP tap secular digitization. Watch for Q1 2026 13Fs (filed ~45 days post-quarter) on valuesense.io for new bets.
FAQ about Chuck Akre's Akre Capital Portfolio
Q: What are the biggest changes in Akre's Q4 2025 portfolio?
A: Key moves include a 39.69% add to Brookfield (BN) to 13.5%, hefty trims in O'Reilly (ORLY, -21.98%) and Moody's (MCO, -18.11%), plus a bold 85.71% increase in Copart (CPRT).
Q: Why is Akre's portfolio so concentrated?
A: Akre focuses on "compounding machines" with durable moats, allocating 93.2% to top 10 for maximum impact. This high-conviction style amplifies returns from deep research, balanced by low 5.6% turnover.
Q: What sectors does Akre favor?
A: Financial services (MA, V, KKR, BN, MCO), software/tech (CSGP, ROP, FICO, ABNB), and specialty retail/services (ORLY, CPRT)—all featuring pricing power and low capital intensity.
Q: How can I track Akre Capital's 13F filings?
A: Use ValueSense's superinvestor tracker at valuesense.io/superinvestors/akre-capital for real-time updates. Note the 45-day 13F lag means Q4 data reflects end-2025 positions; pair with intrinsic value tools for your analysis.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!